Treatment of Newly Diagnosed and Relapsed Hodgkin Lymphoma in Children
نویسندگان
1
2
doi
چکیده
Hodgkin lymphoma (HL) accounts for about 10% of all childhood cancers. Five-year survival rates with modern therapies are now approaching >90-95% as a consequence of its significant sensitivity to both chemotherapy and radiation. The current challenge is to determine how much therapy is needed to improve survival and how to adapt ...